G9925 HCPCS Level II Code: Safety concerns screening not provided, reason not otherwise specified

Contextual Map

Every relationship of G9925 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (40)

• G9905 — Patient not screened for tobacco use[Sibling]— CMS HCPCS Level II code set
• G9906 — Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)[Sibling]— CMS HCPCS Level II code set
• G9907 — Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)[Sibling]— CMS HCPCS Level II code set
• G9908 — Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)[Sibling]— CMS HCPCS Level II code set
• G9909 — Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)[Sibling]— CMS HCPCS Level II code set
• G9910 — Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period[Sibling]— CMS HCPCS Level II code set
• G9911 — Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy[Sibling]— CMS HCPCS Level II code set
• G9912 — Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy[Sibling]— CMS HCPCS Level II code set
• and 32 more

Change history

• January 1, 2018 — Added to the code set [Change history]— CMS release files (code change ledger)

Sources for this page

Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.

Code, descriptors, coverage and pricing attributes Official source data

CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page

Change history and date-of-service validity Official source data

CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page

Comparisons, relationships and the contextual map MedCoder structured relationship

Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears

Summary and FAQ answers MedCoder explanation

Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.

Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates

Nearest Codes in This Family

Official HCPCS Level II classifications closest to G9925 in its code family, with their registry titles.

• G9920 — Screening performed and negative
• G9921 — No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified
• G9922 — Safety concerns screen provided and if positive then documented mitigation recommendations
• G9923 — Safety concerns screen provided and negative
• G9924 — Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other…
• G9926 — Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources
• G9927 — Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
• G9928 — Fda-approved anticoagulant not prescribed, reason not given
• G9929 — Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
• G9930 — Patients who are receiving comfort care only